1. DiNardo, C D, Tiong, I S, Quaglieri, A, Konopleva, M, Wei, A H. . Molecular patterns of response and treatment failure after frontline venetoclax combinations in older patients with AML. In Blood, 135, 791-803. doi:10.1182/blood.2019003988. https://pubmed.ncbi.nlm.nih.gov/31932844/
2. Rehman, Atia, Akram, Afia Muhammad, Chaudhary, Asma, Sayed, Samy, Gaber, Ahmed. 2021. RUNX1 mutation and elevated FLT3 gene expression cooperates to induce inferior prognosis in cytogenetically normal acute myeloid leukemia patients. In Saudi journal of biological sciences, 28, 4845-4851. doi:10.1016/j.sjbs.2021.07.012. https://pubmed.ncbi.nlm.nih.gov/34466057/
3. Brunet, Salut, Martino, Rodrigo, Sierra, Jorge. . Hematopoietic transplantation for acute myeloid leukemia with internal tandem duplication of FLT3 gene (FLT3/ITD). In Current opinion in oncology, 25, 195-204. doi:10.1097/CCO.0b013e32835ec91f. https://pubmed.ncbi.nlm.nih.gov/23385863/
4. Umeda, Masayuki, Ma, Jing, Huang, Benjamin J, Ma, Xiaotu, Klco, Jeffery M. . Integrated Genomic Analysis Identifies UBTF Tandem Duplications as a Recurrent Lesion in Pediatric Acute Myeloid Leukemia. In Blood cancer discovery, 3, 194-207. doi:10.1158/2643-3230.BCD-21-0160. https://pubmed.ncbi.nlm.nih.gov/35176137/
5. Jalte, Meryem, Abbassi, Meriame, El Mouhi, Hinde, Ahakoud, Mohamed, Bekkari, Hicham. 2023. FLT3 Mutations in Acute Myeloid Leukemia: Unraveling the Molecular Mechanisms and Implications for Targeted Therapies. In Cureus, 15, e45765. doi:10.7759/cureus.45765. https://pubmed.ncbi.nlm.nih.gov/37872917/
6. McNeer, Nicole A, Philip, John, Geiger, Heather, Meshinchi, Soheil, Kentsis, Alex. 2019. Genetic mechanisms of primary chemotherapy resistance in pediatric acute myeloid leukemia. In Leukemia, 33, 1934-1943. doi:10.1038/s41375-019-0402-3. https://pubmed.ncbi.nlm.nih.gov/30760869/